Short term swing trade (B): Pharmaceutical stock | Indian stock trading picks on 7 Apr 2026

NOTE

Closing Price: ₹644 (as of Apr 06, 2025)
StopLoss*: Apply on the daily close. After the first target, reset the StopLoss to your buying price.
Duration^: Approximate holding period based on the active trading days (excluding market holidays). Actual holding may vary with the market conditions.
Upside Potential#: Based on median of the suggested buy range.

Shilpa Medicare Limited is a pharma company that makes APIs, finished medicines, biosimilars, and offers contract manufacturing services globally.

It mainly focuses on oncology (cancer) and also produces non-oncology drugs, along with peptides, biologics, and intermediates. The company manufactures tablets, capsules, injectables, and specialty drug delivery forms like patches and oral films.

Founded in 1987, it is headquartered in Raichur, India.

Website: https://www.vbshilpa.com/

Q3 FY26 Earnings Call Summary & Financial Highlights

Earnings Call Summary

Shilpa Medicare reported a strong Q3 FY26 with record revenue of ₹411 crore (+28% YoY) and EBITDA of ₹115 crore (+41% YoY). Margins improved to 28%.
Growth was driven mainly by the Formulations segment, which rose ~50% YoY, with EU sales more than doubling due to strong demand for Nilotinib.
The API business remained steady, growing 11% YoY, supported by both oncology and non-oncology products.
The company also launched NorUDCA, India’s first NAFLD therapy, marking a move into differentiated products.
Financials improved as debt reduced significantly, interest costs declined, and ROCE increased to 17.1%.

Financial Highlights

Metrics	Dec 25 (Q3 FY26)	Sep 25 (Q2 FY26)	QoQ Change	Dec 24 (Q3 FY25)	YoY Change
Revenue (₹ Cr)	411	370	11%	320	28%
Gross Profit Margin (%)	68%	74%	-600 bps	72%	-400 bps
EBITDA (₹ Cr)	115	108	6%	82	40%
EBITDA Margin (%)	28.00%	29.30%	-130 bps	25.6%	+240 bps
Adj. PAT (₹ Cr)	55	44	25%	32	72%
Adj. PAT Margin (%)	13.40%	11.90%	+150 bps	10.0%	+340 bps
PBT (₹ Cr)	74	64	16%	42	76%

Price Performance & Volume Analysis

Price Performance

Volume Analysis

Technical Analysis

Key Observations

After breaking above the trendline resistance, the stock is now set up for a potential upside move.

A trusted swing trading stock advisor India helps traders identify breakout points where momentum is just beginning to build.

Technical Image - Daily Timeframe

Technical Indicators

Oscillators

Indicator	Value	Zone
RSI-14	73.33	Neutral
CCI-14	199.31	OverBought
MFI	90.12	OverBought
ROC	23.89	Positive
Stochastic %K	95.17	Bullish
William %R	-3.42	OverBought

Exponential Moving Averages (EMAs)

EMA	Value	Stock Position
5 EMA	373	Above
10 EMA	359	Above
20 EMA	345	Above
50 EMA	333	Above
100 EMA	339	Above
200 EMA	353	Above

Conclusion

Shilpa Medicare Stock Price Forecast

Based on our stock advice for swing trading, the Shilpa Medicare stock price target will be INR 670 - INR 680 in the next 12-14 trading sessions.

MONEY MANAGEMENT AND TRADING RULES

Buy within the recommended price range. You may allow up to 1% flexibility beyond the range if needed.
No need to rush. The recommendation remains valid for up to 7 days, not just at market open.
Use a trailing stop-loss to protect and lock in profits.
Diversify your trading capital across our other recommended stocks to reduce risk.
Invest responsibly. Trade only with funds you can afford to lose and hedge positions where appropriate.

Analyst Summary

The research analysis is prepared by Arijit Banerjee, CMT, CFTe. He is a veteran trader and an active investor having in-depth knowledge in financial market research, advanced technical analysis, market cycle, algorithmic trading and portfolio management. Arijit is a Chartered Market Technician (CMT) accredited by CMT Association USA, the leading global authority of Technical Analysis and has been honoured by Certified Financial Technician (CFTe) from the International Federation of Technical Analysts, USA. SEBI, the regulatory body of Indian financial market also recognizes him as a Research Analyst (INH300006582).

The views expressed herein are based solely on information available publicly/internal data/other sources believed to be reliable, but is not necessarily all-inclusive and is not guaranteed as to accuracy. The recommendations provided herein is solely for informational purposes and are not intended to be and must not be taken alone as the basis for an investment/trading decision. Trading and investing are subject to market risk and the securities discussed and opinions expressed herein may not be suitable for all investors. To read the full disclosure, please click here.

Your Return Could be Much Better

Increase your Profitable!

10—12 swing trade advice / month
expected upside 6%—8% per trade
short term trade holding 1-2 weeks
minimum capital required ₹2.5 lakh
receive trade advice before 9:00 am
trade ideas by blackbox system, relied on statistics, technical, fundamental, macroeconomics and sentiment
Stocks only — no intraday or F&O